24.02.2013 Views

01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

the endosomal vesicles. The nuclear uptake of<br />

oligonucleotides depended on several factors such as<br />

charge of the particle where positively charged complexes<br />

were required for enhanced nuclear uptake; DOTAP<br />

increased over 100 fold the antisense activity of a specific<br />

anti-luciferase oligonucleotide. Physicochemical studies of<br />

oligonucleotide-liposome complexes of different cationic<br />

lipid compositions indicated that either<br />

phosphatidylethanolamine or negative charges on other<br />

lipids in the cell membrane are required for efficient<br />

fusion with cationic liposome-oligonucleotide complexes<br />

to promote entry to the cell (Jaaskelainen et al, 1994).<br />

Similar results were reported by Lappalainen et al<br />

(1997); digoxigenin-labeled oligodeoxynucleotides<br />

(ODNs) complexed with the polycationic DOSPA and the<br />

monocationic DDAB (with DOPE as a helper lipid) were<br />

uptaken by CaSki cells in culture by endocytosis. The<br />

nuclear membrane was found to pose a barrier against<br />

nuclear import of ODNs which accumulated in the<br />

perinuclear area. Although DOSPA/DOPE liposomes<br />

could deliver ODNs into the cytosol, they were unable to<br />

mediate nuclear import of ODNs; on the contrary<br />

oligonucleotide-DDAB/DOPE complexes with a net<br />

positive charge were released from vesicles into the<br />

cytoplasm; it was determined that DDAB/DOPE mediated<br />

nuclear import of the oligonucleotides.<br />

DOPE-heme (ferric protoporphyrin IX) conjugates,<br />

inserted in cationic lipid particles with DOTAP, protected<br />

oligoribonucleotides from degradation in human serum<br />

and increased oligoribonucleotide uptake into 2.2.15<br />

human hepatoma cells; the enhancing effect of heme was<br />

evident only at a net negative charge in the particles<br />

(Takle et al, 1997). Uptake of liposomes labeled with 111 In<br />

and composed of DC-Chol and DOPE was primarily by<br />

liver, with some accumulation in spleen and skin and very<br />

little in the lung after i.v. tail injection; preincubation of<br />

cationic liposomes with phosphorothioate oligonucleotide<br />

induced a dramatic, yet transient, accumulation of the lipid<br />

in lung which gradually redistributed to liver. The<br />

mechanism of lung uptake involved entrapment of large<br />

aggregates of oligonucleotides within pulmonary<br />

capillaries at 15 min post-injection via embolism; labeled<br />

oligonucleotide was localized primarily to phagocytic<br />

vacuoles of Kupffer cells at 24 h post-injection; nuclear<br />

uptake of oligonucleotide in vivo was not observed<br />

(Litzinger et al, 1996).<br />

Phosphorothioate oligonucleotides were found in most<br />

tissues 48 h after i.p. administration with highest<br />

concentrations in kidney and liver; complexation of the<br />

oligonucleotide with DOTMA did not affect neither the<br />

oligonucleotide uptake nor its tissue distribution in normal<br />

mice but increased the oligonucleotide cellular uptake (4-<br />

10 times) in LOX ascites tumors (Saijo et al, 1994).<br />

Triplex-forming ODNs were delivered to cells in<br />

culture using adenovirus-polylysine-ODN complexes<br />

<strong>Boulikas</strong>: An overview on gene <strong>therapy</strong><br />

24<br />

designed to take advantage of the receptor mediated<br />

endocytosis of adenoviruses to transfer the ODNs to the<br />

cell nucleus; nuclear uptake peaked at 4 h and intact ODN<br />

persisted in the nucleus with a half-life of 12 h<br />

(Ebbinghaus et al, 1996).<br />

E. Fusogenic peptides enhance gene<br />

transfer efficiency<br />

Enveloped viruses have evolved efficient mechanisms<br />

to release their genomes from the endosomes into the<br />

cytoplasm of the host cells; specific envelope proteins of<br />

the nucleocapsid are capable of destabilizing the<br />

endosomal membrane. Therefore, inactivated viruses have<br />

been used to enhance the transfer of plasmids. Addition of<br />

adenoviral particles capable of inducing endosome lysis<br />

(Blumenthal et al, 1986), mediated by a conformational<br />

change in the adenovirus penton protein induced at the<br />

lower pH of endosomes (Seth, 1994) can increase<br />

transfection efficiency 100-1000 fold using 10 9 adenoviral<br />

particles/ml and the transferrin receptor (Curiel et al,<br />

1991; Cotten et al, 1992; Wagner et al, 1992b; Cristiano et<br />

al, 1993; Morishita et al, 1993; Harries et al, 1993; Curiel,<br />

1994; reviewed by Ledley, 1995).<br />

Use of fusogenic peptides from influenza virus<br />

hemagglutinin HA-2 enhanced greatly the efficiency of<br />

transferrin-polylysine-DNA complex uptake by cells; in<br />

this case the peptide was linked to polylysine and the<br />

complex was delivered by the transferrin receptormediated<br />

endocytosis (Wagner et al, 1992a; Plank et al,<br />

1994). This peptide had the sequence:<br />

GLFEAIAGFIENGWEGMID GGGYC and was able to<br />

induce the release of the fluorescent dye calcein from<br />

liposomes prepared with egg yolk phosphatidylcholine<br />

which was higher at acidic pH; this peptide was also able<br />

to increase up to 10-fold the anti-HIV potency of antisense<br />

oligonucleotides, at a concentration of 0.1-1 mM, using<br />

CEM-SS lymphocytes in culture (Bongartz et al, 1994).<br />

This peptide changes conformation at the slightly more<br />

acidic environment of the endosome destabilizing and<br />

breaking the endosomal membrane (Murata et al, 1992;<br />

Bullough et al, 1994). Fusogenic peptides have been used<br />

by other investigators (Midoux et al, 1993; Kamata et al,<br />

1994). It is thought that several fusogenic peptides selfassemble<br />

following their conformational change forming a<br />

transmembrane channel (Bongartz et al, 1994).<br />

Sendai virosomes were effective for delivering AAV<br />

neuropeptide Y (NPY) cDNA constructs in vivo.<br />

Injections into brain neocortex of Sendai-virosome<br />

encapsulated rAAV construct expressing NPY increased<br />

NPY-like immunoreactivity in neurons but not glia;<br />

injections into the rat hypothalamic para-ventricular<br />

nucleus increased body weight and food intake for 21 days<br />

(Wu et al, 1996). Tomita et al (1996) have found that<br />

newborn mice can sustain expression of the insulin gene

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!